“G-Protein-coupled estrogen receptor (GPER)-specific agonist G-1 reduces cell proliferation in gastrointestinal cancer cells independently of GPER1 receptor presence”, Prospect. Pharm. Sci., vol. 24, no. 2, pp. 79–89, May 2026, doi: 10.56782/pps.743.